Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,055.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 2,155.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 114
  • Market Cap: £1,357.06m
  • RiskGrade: 128
  • Beta: 0.01

Latest ShareCast News

London close: Stocks finish higher as US economy contracts

By Josh White

Date: Wednesday 30 Apr 2025

(Sharecast News) - London stocks extended their gains on Wednesday, after fresh data from the US showed a slowing in consumer price growth, alongside the country's first economic contraction since 2022.

Genus Regulatory News

Appointment of Financial Adviser & joint Broker 09-May-2025 09:25 RNS
Total Voting Rights 01-May-2025 14:28 RNS
PRRS Resistant Pig – FDA Approval 30-Apr-2025 07:00 RNS
Notification of Major Holdings 25-Apr-2025 16:30 RNS
Notification of Major Holdings 25-Apr-2025 16:28 RNS

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,055.00p
Change Today 5.00p
% Change 0.24 %
52 Week High 2,155.00
52 Week Low 1,424.00
Volume 114
Shares Issued 66.04m
Market Cap £1,357.06m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.82% below the market average89.82% below the market average89.82% below the market average89.82% below the market average89.82% below the market average
91.67% below the sector average91.67% below the sector average91.67% below the sector average91.67% below the sector average91.67% below the sector average
Price Trend
42.71% above the market average42.71% above the market average42.71% above the market average42.71% above the market average42.71% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average
Income
93.45% below the market average93.45% below the market average93.45% below the market average93.45% below the market average93.45% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
92.64% below the market average92.64% below the market average92.64% below the market average92.64% below the market average92.64% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 1
Sell 0
Strong Sell 0
Total 10
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for 14-May-2025

Time Volume / Share Price
08:17 14 @ 2,055.00p
08:01 0 @ 2,015.00p
08:00 100 @ 2,069.85p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page